Clinical Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
SVRA | C | Savara, Inc. | -8.19 | |
SRPT | B | Sarepta Therapeutics, Inc. | -0.36 | |
SLRX | F | Salarius Pharmaceuticals, Inc. | -1.46 | |
SAGE | F | Sage Therapeutics, Inc. | -3.57 | |
REGN | C | Regeneron Pharmaceuticals, Inc. | 0.60 | |
PULM | C | Pulmatrix, Inc. | -3.31 | |
ORGS | F | Orgenesis Inc. | 4.69 | |
ONCT | D | Oncternal Therapeutics, Inc. | -5.28 | |
NVAX | F | Novavax, Inc. | 98.66 | |
NXTC | D | NextCure, Inc. | -4.07 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Medical Devices
Related Stock Lists:
Biopharmaceutical
Medicine
Biotechnology
Cancer
Infectious Diseases
Solid Tumors
Clinical Research
Cystic Fibrosis
Influenza
Ovarian Cancer
Rare Diseases
Sarcoma
Adjunctive Therapy
Advanced Solid Tumors
Angiogenesis
Antibodies
Anticonvulsants
Antidepressants
Antisense RNA
Assay Development Services
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
PINK | D | Simplify Health Care ETF | 8.61 | |
BBP | D | BioShares Biotechnology Products Fund | 7.9 | |
IDNA | C | iShares Genomics Immunology and Healthcare ETF | 7.13 | |
IBRN | D | iShares Neuroscience and Healthcare ETF | 5.33 | |
SHLD | A | Global X Defense Tech ETF | 4.91 |
Compare ETFs
- Clinical Development
Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles